Xeljanz Side Effects

The FDA is investigating the Xeljanz side effects. Prior warnings led to changes in drug labeling, black box information, and prescribing restrictions, but a new warning is possible. The drug may increase the risk of serious infections, including pneumonia, cellulitis, urinary tract infections, and herpes zoster. Xeljanz may also increase the risk of cancer. If you suspect you have developed an infection, report it right away to your healthcare provider.

Xeljanz can also cause pulmonary embolism, a potentially life-threatening blood clot in the lung. Although the causal link between Xeljanz and pulmonary embolism is unknown, the FDA's decision to refuse approval of the drug came two years after a previous warning. Xeljanz, an oral drug, was associated with an increased risk of pulmonary embolism, blood clots, and thrombosis, at doses of up to 10 mg twice daily. These side effects also occurred in patients taking lower doses of the drug.

Other Xeljanz side effects include a decrease in white blood cells, low hemoglobin levels, and abnormal liver enzymes. Your healthcare provider will monitor your blood levels and advise you if any changes occur. If any of these side effects become significant, your healthcare provider may temporarily stop your Xeljanz use. If you have an infection or are pregnant, you should consult your healthcare provider about your condition.

Xeljanz is approved for use in the U.S. but the European Union has prohibited the drug's use. However, there are several potential Xeljanz side effects. Taking this drug can increase the risk of cancer and infections. Some patients may also develop ulcerative colitis. It has been used to treat other immune-related disorders, including rheumatoid arthritis and psoriatic arthritis.

XELJANZ has been studied in patients with moderate-to-severe UC. It was approved for use in this disease in 2012. The latest studies have documented severe Xeljanz side effects. In patients with rheumatoid arthritis, blood clots can form in the lungs. Some of these complications can be fatal. These serious Xeljanz side effects may have fatal consequences.

Xeljanz is a prescription medication that is approved for the treatment of autoimmune disorders. It is also used for people who have tried other medications containing tumor necrosis factor. It is a member of the janus kinase inhibitor class. The drug may also cause gastrointestinal perforations. While the number of cases of gastrointestinal perforations is still low, it is worth discussing with your health care provider to see if you are at risk for any of these serious side effects.

Some of the more serious Xeljanz side effects are headache, nausea, and diarrhea. This drug is approved by the FDA to treat polyarticular juvenile idiopathic arthritis (pcJIA), but there are also serious complications associated with it. Fortunately, most of the adverse effects are mild and minor, and there are only a few serious ones. The FDA Adverse Events Reporting System received 42,528 reports of Xeljanz adverse reactions between 2013 and 2018.